Big pharma' urged to develop treatments for global health

Anne Gulland reports on how the 2018 Index found that just five firms: GSK, Johnson & Johnson, Sanofi, Merck and Novartis are conducting two thirds of the research and development into diseases that urgently need treatments. She notes: "GSK topped the overall list of pharmaceutical companies in terms of providing access, followed by Novartis, Johnson & Johnson and Merck. Bottom of the list of 20 global companies was the US firm Eli Lilly."